These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 23897641

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The experience of using fingolimod (gilenya) in patients with relapsing-remitting multiple sclerosis].
    Kotov SV, Fedorova SI, Iakushina TI, Lizhdvoĭ VIu.
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):74-8. PubMed ID: 23528598
    [Abstract] [Full Text] [Related]

  • 26. Fingolimod for multiple sclerosis.
    Pelletier D, Hafler DA.
    N Engl J Med; 2012 Jan 26; 366(4):339-47. PubMed ID: 22276823
    [No Abstract] [Full Text] [Related]

  • 27. Critical vasospasm during fingolimod (FTY720) treatment in a patient with multiple sclerosis.
    Schwarz A, Korporal M, Hosch W, Max R, Wildemann B.
    Neurology; 2010 Jun 15; 74(24):2022-4. PubMed ID: 20548047
    [No Abstract] [Full Text] [Related]

  • 28. Oral cladribine and fingolimod for relapsing multiple sclerosis.
    Mann H.
    N Engl J Med; 2010 May 06; 362(18):1738; author reply 1739-40. PubMed ID: 20445188
    [No Abstract] [Full Text] [Related]

  • 29. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    Castillo-Trivino T, Lopetegui I, Alarcón-Duque JA, López de Munain A, Olascoaga J.
    J Neurol Neurosurg Psychiatry; 2015 Aug 06; 86(8):931-2. PubMed ID: 25835036
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Occurrence of ecchymotic angioedema-like cutaneous lesions as a possible side effect of fingolimod.
    Masera S, Chiavazza C, Mattioda A, Superti G, Beggiato E, Crosasso P, Broganelli P, Pinessi L, Cavalla P.
    Mult Scler; 2014 Oct 06; 20(12):1666-7. PubMed ID: 24603883
    [No Abstract] [Full Text] [Related]

  • 32. Fingolimod: cardiovascular deaths.
    Prescrire Int; 2012 Apr 06; 21(126):99. PubMed ID: 22515137
    [No Abstract] [Full Text] [Related]

  • 33. Fingolimod-associated amenorrhea: a report of three cases.
    Alroughani R.
    Mult Scler; 2014 Oct 06; 20(12):1662-4. PubMed ID: 24515730
    [Abstract] [Full Text] [Related]

  • 34. Oral fingolimod (FTY720) for relapsing multiple sclerosis.
    Kappos L, Antel J, Comi G, Montalban X, O'Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW, FTY720 D2201 Study Group.
    N Engl J Med; 2006 Sep 14; 355(11):1124-40. PubMed ID: 16971719
    [Abstract] [Full Text] [Related]

  • 35. Management of fingolimod in clinical practice.
    Thomas K, Ziemssen T.
    Clin Neurol Neurosurg; 2013 Dec 14; 115 Suppl 1():S60-4. PubMed ID: 24321158
    [Abstract] [Full Text] [Related]

  • 36. Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.
    Thomas K, Schrötter H, Halank M, Ziemssen T.
    BMC Neurol; 2014 Jun 07; 14():126. PubMed ID: 24906818
    [Abstract] [Full Text] [Related]

  • 37. Fingolimod therapy for multiple sclerosis.
    Willis MA, Cohen JA.
    Semin Neurol; 2013 Feb 07; 33(1):37-44. PubMed ID: 23709211
    [Abstract] [Full Text] [Related]

  • 38. Management of fingolimod-associated macular edema.
    Chui J, Herkes GK, Chang A.
    JAMA Ophthalmol; 2013 May 07; 131(5):694-6. PubMed ID: 23538612
    [No Abstract] [Full Text] [Related]

  • 39. Switching from natalizumab to fingolimod: an observational study.
    Sempere AP, Martín-Medina P, Berenguer-Ruiz L, Pérez-Carmona N, Sanchez-Perez R, Polache-Vengud J, Feliu-Rey E.
    Acta Neurol Scand; 2013 Aug 07; 128(2):e6-e10. PubMed ID: 23336398
    [Abstract] [Full Text] [Related]

  • 40. Fingolimod for the treatment of relapsing multiple sclerosis.
    Singer BA.
    Expert Rev Neurother; 2013 Jun 07; 13(6):589-602. PubMed ID: 23738997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.